-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
January 08, 2025 - ADHD
Individuals 17 years of age or younger
unless findings are reported separately
for older participants … We will obtain all published reports providing data on a study (a study is defined
by the included participants … We will document the targeted population, abstract reported
characteristics for all participants (participants … included in the study to
identify studies with narrow eligibility criteria, studies that excluded participants … with
comorbidities, or that had more complex participants than typically seen in the community.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
January 08, 2025 - e.g., use of a scale or checklist) and whether adverse event data were collected actively
(e.g., all participants … were asked about the occurrence of specific harms) or passively (e.g.,
participants might have reported … population included in the study to identify those with
narrow eligibility criteria, that excluded participants … with comorbidities, that had more complex
participants than typically seen in the community, and those … that had run-in periods where
adherence was tested and participants were excluded for non-adherence
-
effectivehealthcare-admin.ahrq.gov/products/management-adhd-adults/protocol
February 01, 2025 - instrument) Individuals 17 years of age or younger unless findings are reported separately for older participants … were asked about the occurrence of specific harms) or passively (e.g., participants might have reported … population included in the study to identify those with narrow eligibility criteria, that excluded participants … with comorbidities, that had more complex participants than typically seen in the community, and those … that had run-in periods where adherence was tested and participants were excluded for non-adherence.
-
effectivehealthcare-admin.ahrq.gov/products/hyperactivity-disorder/protocol
February 01, 2025 - diagnosis is unclear, however, and their performance may vary depending on the characteristics of the ADHD participants … diagnosis of ADHD Individuals 17 years of age or younger unless findings are reported separately for older participants … We will obtain all published reports providing data on a study (a study is defined by the included participants … We will document the targeted population, abstract reported characteristics for all participants (participants … with comorbidities, or that had more complex participants than typically seen in the community.
-
effectivehealthcare-admin.ahrq.gov/products/COVID-19-pharmaceutical-treatments/research
September 01, 2023 - Publications reporting on the same participants will be consolidated into one study record. … beginning of treatment) Timing category Less than or equal to 45 days Greater than 45 days Number of participants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
June 05, 2024 - % of participants <50
years (if reported)
Text
% Female
Note … Text
Age range of included population (if
reported)
Text
% of participants ≥65 years (if … Radio Yes
No
Other
Length of followup (in years) used to
consider participants cancer free … with cancer identified
through clinical presentation (if reported
Text
N (%) of participants … N True Negatives(participants without cancer and
negative test)
N False Positives (participants
-
effectivehealthcare-admin.ahrq.gov/products/cell-free-dna/protocol
July 01, 2024 - Text % of participants ≥65 years (if reported) Text % of participants <50 years (if reported) … Text Age range of included population (if reported) Text % of participants ≥65 years (if reported … ) Text % of participants <50 years (if reported) Text % Female Note: report for study population … with cancer identified through clinical presentation (if reported Text N (%) of participants with … True Negatives(participants without cancer and negative test) N False Positives (participants without
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
May 01, 2017 - n/N (%)
Odds ratio
(95% CI)
Goldstein 2005 15689760
7/1996-6/1999
U.S.
1 year Ear plugs All Participants … 42/90 (46.7) 0.68 (0.37 – 1.25)
No precautions All Participants 46/82 (56.1) [reference]
Ear plugs … 18/30 (60.0) 0.71 (0.29 – 1.76)
Ear plugs† All Participants 13/15 (86.7) 3.10 (0.64 – 15.04)
No precautions … All Participants 42/62 (67.7) [reference]
†Randomized to the nonswimming group, but self-selected to … Across RCTs relative to KQs 1 and 2, there was universal
lack of blinding of participants and, in many
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - Performance bias
Blinding of participants and
personnel Assessments should be
made for each main … Performance bias due to knowledge of the allocated interventions by
participants and personnel during … Were participants analyzed according to their initial intervention group throughout
follow up? … Risk of bias judgment
Bias in
selection of
participants
into the study
2.1. … 6.2 Were outcome assessors unaware of the intervention received by study participants?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - Data are often insufficient to assess the methods used to
select participants.
45
In addition, because … Participants are asked in structured questionnaires or interviews about the occurrence of
specific adverse … Passive surveillance of
harms
Participants are not specifically asked about or tested for the occurrence … Was the NUMBER of participants that withdrew or were lost to follow-up specified for each study group … Was the TOTAL NUMBER of participants affected by harms specified for each study arm?
14.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - Data are often insufficient to assess the methods used to
select participants.
45
In addition, because … Participants are asked in structured questionnaires or interviews about the occurrence of
specific adverse … Passive surveillance of
harms
Participants are not specifically asked about or tested for the occurrence … Was the NUMBER of participants that withdrew or were lost to follow-up specified for each study group … Was the TOTAL NUMBER of participants affected by harms specified for each study arm?
14.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
June 01, 2015 - The research team sent written invitations to the potential stakeholders/participants (see
Appendix … Participation at all stages was voluntary, and participants were free to decline to participate in
any … Audio recordings were made after the participants
provided verbal permission to record the discussions … We incorporated suggestions from pilot participants before sending the final
link to stakeholders. … Participants
will then take part in a modified Delphi process to prioritize research topics.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/ebc-webinar-slides.pptx
June 01, 2014 - private chat message to the “HOST 1 COMMUNITY FORUM (Host)” or a public message to “Everyone” which all participants … private chat message to the “HOST 1 COMMUNITY FORUM (Host)” or a public message to “Everyone” which all participants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
February 01, 2018 - Special topics:
Crossover trials
• In a crossover trial all participants receive both the treatment … control/pooled)
Special topics:
Cluster-randomized trials
• Cluster randomized trials are those where participants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - led to differences
in the numbers reported for allocation of participants. … Participants were contacted no more than three times. … Participants were asked to
complete the questionnaire by July 16. … (Figure 3) and the numbers of participants by stakeholder
category (Table 1). … Participants were not
substantially different from non-participants.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - of the effectiveness of various categories of
DSTs, defined by degree of tailoring to patients and participants … only to the patient or used during
the consultation, or by levels of tailoring a DST to individual participants … Example categories
for tailoring of DSTs to participants include suggesting a decision in the end, based
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-comments.pdf
May 21, 2020 - We recommend adding in any
available information of participants’ demographics in the
studies reviewed
-
effectivehealthcare-admin.ahrq.gov/products/kidney-stone-prevention/research
December 01, 2019 - Allopurinol effectiveness may be limited to participants with hyperuricosuria or hyperuricemia.
-
effectivehealthcare-admin.ahrq.gov/products/ptsd-adults-trauma-interventions/research
December 01, 2019 - Participants suffered from symptoms of PTSD but did not meet diagnostic criteria for PTSD.
-
effectivehealthcare-admin.ahrq.gov/products/autism-update/research
December 01, 2019 - comparative studies (with treatment and comparison groups) of behavioral interventions with at least 10 participants